Mukul Singhal

Suggest Changes
  • Citations Per Year
Learn More
BACKGROUND Glucagon-like peptide 1 receptor agonists (GLP-1RAs) are recommended as add-on therapy in patients with uncontrolled type 2 diabetes (T2D), with no specific guidance as to timing versus(More)
  • 1